Directory

>

Laura Hansen

avatar

Laura Hansen

Vice President of Investor Relations | Denali Therapeutics

Burlingame, California, United States

View contact details (it's free)

Laura Hansen

Summary

Laura Hansen is an accomplished Vice President of Investor Relations at Denali Therapeutics, specializing in the intersection of science and investor communications. With a strong academic background, including a Ph.D. in Biological Sciences from the University of Texas at Austin, she has built a career in the biotech and pharmaceuticals sector over the past two decades. Her leadership experience spans multiple organizations, where she has successfully managed corporate communications and investor relations strategies. Laura's expertise in scientific communication has enabled her to effectively bridge the gap between complex scientific concepts and investor understanding. She has a proven track record of fostering relationships with stakeholders and enhancing corporate visibility in competitive markets. Passionate about advancing healthcare through effective communication, she remains actively engaged in the biotech community. Laura's diverse experience across startups and established firms showcases her adaptability and broad knowledge of the industry.

General

Generalist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Leadership Development

Organisational experience

Corporate Experience

Startup Experience

Laura Hansen

Work Experience

company logo

Vice President of Investor Relations at

Denali Therapeutics

September 2020 - Present

company logo

Vice President Corporate Affairs at

Blackthorn Therapeutics

March 2019 - September 2020

company logo

Vice President of Investor Relations at

Aimmune Therapeutics

February 2016 - March 2019

💼

Senior Director, Corporate Communications at

August 2012 - February 2016

company logo

Director, Corporate Communications at

FibroGen, Inc.

November 2002 - July 2012

company logo

Director, Corporate Communications and Investor Relations at

Corvas International, Inc

July 2001 - July 2002

💼

Account Supervisor at

Susan E Atkins And Assoc

August 1999 - July 2001

Logos provided by Logo.dev

Laura Hansen

Education

The University of Texas at Austin, Ph.D.

January 1993 - January 1999

The University of Texas at Austin, B.S.

January 1988 - January 1992

Frequently Asked Questions about Laura Hansen

What is Laura Hansen email address?

Laura Hansen's primary email address is ************@denalitherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Laura Hansen work for?

Laura Hansen is a Vice President of Investor Relations at Denali Therapeutics, a company specializing in Commercial physical research.

Where Laura Hansen graduated from?

Laura Hansen holds a degree in Biological Sciences from The University of Texas at Austin.

How can I directly contact Laura Hansen?

To contact Laura Hansen directly, you can use the email address ************@denalitherapeutics.com. Complete contact information is available upon registration with Muraena.

Who is Laura Hansen?

Laura Hansen is an accomplished Vice President of Investor Relations at Denali Therapeutics, specializing in the intersection of science and investor communications. With a strong academic background, including a Ph.D. in Biological Sciences from the University of Texas at Austin, she has built a career in the biotech and pharmaceuticals sector over the past two decades. Her leadership experience spans multiple organizations, where she has successfully managed corporate communications and investor relations strategies. Laura's expertise in scientific communication has enabled her to effectively bridge the gap between complex scientific concepts and investor understanding. She has a proven track record of fostering relationships with stakeholders and enhancing corporate visibility in competitive markets. Passionate about advancing healthcare through effective communication, she remains actively engaged in the biotech community. Laura's diverse experience across startups and established firms showcases her adaptability and broad knowledge of the industry.

Laura`s contact details

mail

************@denalitherapeutics.com

*******@fibrogen.com

Colleagues

avatar
Sarah Rhodes Martin

VP, US ETV Franchise and Global Product Strategy

avatar
Peter Chin

Sr. Vice President & Head of Late-Stage Clinical Development and Medical Affairs

avatar
Alexander Schuth

Director Board Of Directors

avatar
Eric Strait

Executive Director, Legal Department

avatar
Anthony Delucchi

Vice President, Technical Operations

avatar
Terry Hudson

Executive Director

avatar
Mitesh Shridhar

Executive Director, Corporate Development

avatar
Leah Frautschy

Vice President, Clinical Manufacturing

avatar
Katie Peng

Board Member

View Contact details (it's free)
Request Profile Removal